Trelstar Related Clinical Trials
Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI [Recruiting]
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer [Terminated]
Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls [Active, not recruiting]
Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty [Completed]
Triptorelin for Ovary Protection in Childhood Onset Lupus [Completed]
Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer [Completed]
Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer [Completed]
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. [Recruiting]
A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. [Recruiting]
Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty [Completed]
Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg [Completed]
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism [Active, not recruiting]
Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT) [Terminated]
Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer [Terminated]
Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin [Completed]
Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study [Active, not recruiting]
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer [Completed]
TRial on the Endocrine Activity of Neoadjuvant Degarelix [Recruiting]
Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer [Completed]
Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome [Recruiting]
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery [Completed]
Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02 [Active, not recruiting]
Study to Evaluate a Subcutaneous Four Months Sustained-Release Formulation of Triptorelin in Patients With Prostate Cancer [Terminated]
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure [Active, not recruiting]
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer [Terminated]
High-Dose Brachytherapy in Treating Patients With Prostate Cancer [Recruiting]
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 [Active, not recruiting]
A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703) [Completed]
Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients [Recruiting]
Luteal Phase Plus GnRH-agonist After GnRH-agonist Triggering Combined With Low Dose HCG in IVF (LPGGTHI) [Recruiting]
GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study [Completed]
Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval [Recruiting]
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer [Recruiting]
Endometrial Receptivity After GnRH Agonist Triggering [Recruiting]
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer [Recruiting]
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer [Not yet recruiting]
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration [Completed]
Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients [Completed]
Micro RNAs to Predict Response to Androgen Deprivation Therapy [Recruiting]
Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve [Recruiting]
A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height [Recruiting]
Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF [Recruiting]
Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer [Recruiting]
The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes [Recruiting]
A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months [Recruiting]
Suppression of Ovarian Function and Either Tamoxifen or Exemestane With or Without Chemotherapy in Treating Premenopausal Women With Resected Breast Cancer [Terminated]
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783) [Completed]
Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF [Recruiting]
Administration of GnRH Antagonist to Oocyte Donation Recipients [Completed]
GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles [Recruiting]
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles [Recruiting]
Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery [Recruiting]
The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer [Recruiting]
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy [Completed]
GnRH Agonist Pretreatment in Hysteroscopic Myomectomy [Completed]
Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days [Completed]
The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis [Completed]
Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles [Terminated]
GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles [Completed]
Hormone Therapy in Treating Patients With Advanced Prostate Cancer [Completed]
Androgen Deprivation Therapy in Advanced Salivary Gland Cancer [Recruiting]
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
GP Extended Action Triptorelin [Completed]
Multidisciplinary Study of Androgen Deprivation Therapy (ADT) in Prostate Cancer [Recruiting]
GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation [Recruiting]
Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG [Active, not recruiting]
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children [Recruiting]
GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer [Recruiting]
Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial [Recruiting]
Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients [Recruiting]
Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome [Recruiting]
Investigation of Early Hormonotherapy Efficacy of Prostate Cancer [Recruiting]
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse [Active, not recruiting]
Decapeptyl SR With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women [Recruiting]
Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients [Recruiting]
Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation [Recruiting]
Hypo-fractionated Proton Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer [Recruiting]
Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression [Not yet recruiting]
IVF/ICSI Protocols in Poor Responders With Growth Hormone [Recruiting]
Long Protocol in Poor Responders [Recruiting]
Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration [Recruiting]
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02 [Active, not recruiting]
A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel [Active, not recruiting]
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients [Terminated]
Microflare Protocol in Poor Responders [Completed]
Oral Contraceptive Pill and GnRH Antagonist Versus Long Protocol in IVF Patients [Completed]
Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors [Completed]
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer [Terminated]
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer [Completed]
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients [Recruiting]
Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization [Completed]
|